It is estimated that the total annual financial cost for pain management in the US exceeds
100 billion dollars. However, when indirect costs are included, such as functional disability …

Objective: Finding an effective preventive agent for the individual migraineur is often long
and frustrating. An individual-specific, efficacy-predicting tool would be invaluable in …

Migraine is not only known to be one of the most common causes of a headache around the
globe but is also the leading neurologic cause of disability worldwide. Migraine has …

The disability of migraine, a highly prevalent condition, is worsened by a second comorbid
chronic pain condition. There is evidence of a relationship between migraine and several …

Background Common treatments for chronic migraine headaches include injection of
corticosteroid and anesthetic agents at local trigger sites. However, the effects of therapy are …

Objective This study aimed to describe the demographic and clinical characteristics of
migraineurs prescribed≥ 1 migraine prophylactic therapy, and to analyze their therapeutic …

Objectives: Migraine is a neurological disease with a high frequency of incidence. The new
monoclonal antibodies selective for the calcitonin gene-related peptide and its ligand (anti …

Background: The right choice of migraine headache medications can be controlled by
knowing the knowledge, attitude, and practice among pharmacists because pharmacists …

Migraine is a common neurologic condition marked by recurrent episodes of headache. Its
pathophysiology is highly complex involving neuronal, inflammatory and vascular …

Medication-overuse headache (MOH) is a disabling secondary headache disorder, with
challenging consequences for affected patients and health care resources. It is defined as …